DSPG3/EPYC Antibody (340908) [Janelia Fluor® 549]
Novus Biologicals, part of Bio-Techne | Catalog # FAB2875I
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Western Blot
Label
Janelia Fluor 549
Antibody Source
Monoclonal Rat IgG2B Clone # 340908
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse DSPG3
Ala20-Ile322
Accession # P70186
Ala20-Ile322
Accession # P70186
Specificity
Detects mouse DSPG3 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 50% cross-reactivity with recombinant human DSPG3 is observed.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2B
Applications for DSPG3/EPYC Antibody (340908) [Janelia Fluor® 549]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: DSPG3
Long Name
Dermatan Sulfate Proteoglycan 3
Alternate Names
Epiphycan, EPYC, PG-Lb, SLRR3B
Gene Symbol
EPYC
Additional DSPG3 Products
Product Documents for DSPG3/EPYC Antibody (340908) [Janelia Fluor® 549]
Product Specific Notices for DSPG3/EPYC Antibody (340908) [Janelia Fluor® 549]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...